CMS-D008
/ China Medical System
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
March 04, 2026
China Medical System Holdings Says CMS-D008 Receives Drug Clinical Trial Approval From China's NMPA
(TradingView)
New trial • Obesity
March 05, 2026
China Medical System Holdings Limited…is pleased to announce that self-developed innovative drug INHBE-targeting small nucleic acid drug CMS-D008 injection ('CMS-D008') received the Drug Clinical Trial Approval Notice issued by National Medical Products Administration ('NMPA') on 4 March 2026
(JCN Newswire)
- "The NMPA has approved the conduct of clinical trials of CMS-D008 injection for overweight or obese individuals."
New trial • Obesity
1 to 2
Of
2
Go to page
1